The embodiments described herein relate to a self-positioning, quick-deployment low profile transvenous electrode system for sequentially pacing both the atrium and ventricle of the heart in the dual chamber mode, and methods for deploying the same.

Medical devices that are formed from a polymeric matrix including a first polymer and a functionalized polymer are provided. The medical devices may include a functionalized polymer such as maleic anhydride functionalized polymer. The burst strength and/or the hoop strength of the medical devices including the functionalized polymer may be greater than the burst strength and/or the hoop strength of control medical devices. However, the durometer of the medical devices may be substantially equal to the durometer of the control medical devices. Methods of manufacturing medical devices including a functionalized polymer are also provided.

A medical instrument or device, such as a catheter, has echogenic properties, in addition to or as an alternative to radiopaque properties, to facilitate detection of the medical instrument or device during medical procedures using suitable imaging methods, such as ultrasound imaging and/or x-ray imaging methods. In example embodiments, an example catheter has a relatively increased radiopacity and echogenicity to facilitate a clinician with detecting the catheter with ultrasound imaging and/or x-ray imaging methods to assist the clinician with the insertion, placement, and/or maintenance of the catheter, for example.

Disclosed is a balloon catheter that can comprise an elongate support member, an inflation tube, a guidewire tube and a balloon. The guidewire tube can define a guidewire port at its proximal end, and can extend from the port through an opening in a wall of the elongate support member and distally through a first lumen of the elongate support member, in some cases to the distal end of the catheter. The inflation tube can be disposed over a distal portion of the elongate support member, a portion of the guidewire tube, a portion of the inner assembly, or any combination thereof, forming a second lumen. The distal end of the balloon can be attached to the guidewire tube and the proximal end of the balloon can be attached to the inflation tube. The inside of the balloon can be in fluid communication with the first lumen and with the second lumen, allowing the balloon to be inflated and/or deflated. The elongate support member can also have cuts in it. For example, the elongate support member can have apertures formed in it, or apertures and spiral cuts.

Disclosed is a balloon catheter that can comprise an elongate support member, an inflation tube, a guidewire tube and a balloon. The guidewire tube can define a guidewire port at its proximal end, and can extend from the port through an opening in a wall of the elongate support member and distally through a first lumen of the elongate support member, in some cases to the distal end of the catheter. The inflation tube can be disposed over a distal portion of the elongate support member, a portion of the guidewire tube, a portion of the inner assembly, or any combination thereof, forming a second lumen. The distal end of the balloon can be attached to the guidewire tube and the proximal end of the balloon can be attached to the inflation tube. The inside of the balloon can be in fluid communication with the first lumen and with the second lumen, allowing the balloon to be inflated and/or deflated. The elongate support member can also have cuts in it. For example, the elongate support member can have apertures formed in it, or apertures and spiral cuts.

Catheters and methods for supporting a guidewire or delivering a radiopaque, diagnostic or therapeutic agent through a vessel stenosis or other tortuous anatomy are disclosed. A catheter can comprise an elongate shaft body and a tip member disposed at a distal end of the shaft body. The shaft body can extend from a proximal end to the distal end and can define an inner lumen. The shaft body can include a liner, a braid member surrounding the liner, a multi-layer coil surrounding the braid member, and a polymer cover surrounding the multi-layer coil. An outer surface portion of the polymer cover can include one or more helical threads, which can be enveloped in an outer wrapper. The tip member can be made from a metal or a polymer. Polymer tip members can include a hard or semi-hard distal tip.

Catheters and methods for supporting a guidewire or delivering a radiopaque, diagnostic or therapeutic agent through a vessel stenosis or other tortuous anatomy are disclosed. A catheter can comprise an elongate shaft body and a tip member disposed at a distal end of the shaft body. The shaft body can extend from a proximal end to the distal end and can define an inner lumen. The shaft body can include a liner, a braid member surrounding the liner, a multi-layer coil surrounding the braid member, and a polymer cover surrounding the multi-layer coil. An outer surface portion of the polymer cover can include one or more helical threads, which can be enveloped in an outer wrapper. The tip member can be made from a metal or a polymer. Polymer tip members can include a hard or semi-hard distal tip.

An alcohol-resistant siliconized polycarbonate polyurethane can include a soft segment and a hard segment. The soft segment can include a polycarbonate polyol and a polysiloxane, which can be present in an amount less than the polycarbonate polyol. The hard segment can include an isocyanate and a chain extender. Peripherally inserted central catheter (PICC) devices can include one or more components that are at least partially formed from one or more formulations of the siliconized polycarbonate polyurethane catheter. The PICC devices can withstand alcohol locking, and can be power injectable both before and after alcohol locking events.

The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.

The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.